1. The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis
   Shoudu Zhang et al, 2023, Frontiers in Immunology CrossRef
2. APOBEC3B, a molecular driver of mutagenesis in human cancers
   Jun Zou et al, 2017, Cell & Bioscience CrossRef
3. The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside
   Chenchen Ma et al, 2022, Molecules CrossRef
4. The eQTL-missense polymorphisms of APOBEC3H are associated with lung cancer risk in a Han Chinese population
   Meng Zhu et al, 2015, Scientific Reports CrossRef
5. A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils
   Sachini U. Siriwardena et al, 2019, Molecular and Cellular Biology CrossRef
6. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer
   Shixiang Wang et al, 2018, Oncogene CrossRef
7. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis
   Catherine E. Waters et al, 2015, Oncotarget CrossRef
8. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition
   Rémi Buisson et al, 2017, Cancer Research CrossRef
9. Constructing an APOBEC-related gene signature with predictive value in the overall survival and therapeutic sensitivity in lung adenocarcinoma
   Yu Luo et al, 2023, Heliyon CrossRef
10. APOBEC3B expression in drug resistant MCF-7 breast cancer cell lines
    Onder Onguru et al, 2016, Biomedicine & Pharmacotherapy CrossRef
11. Association between targeted somatic mutation (TSM) signatures and HGS‐OvCa progression
    Robyn A. Lindley et al, 2016, Cancer Medicine CrossRef
12. Viral subversion of APOBEC3s: Lessons for anti-tumor immunity and tumor immunotherapy
    Faezeh Borzooee et al, 2018, International Reviews of Immunology CrossRef
13. Evolutionary Comparative Analyses of DNA-Editing Enzymes of the Immune System: From 5-Dimensional Description of Protein Structures to Immunological Insights and Applications to Protein Engineering
    Atefeh Ghorbani et al, 2021, Frontiers in Immunology CrossRef
14. AID/APOBEC deaminases and cancer
    Stefan Rebhandl et al, 2015, Oncoscience CrossRef
15. Research on the influence of APOBEC family on the occurrence, diagnosis, and treatment of various tumors
    Jing Yang et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
16. Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation
    Sundaramoorthy Revathidevi et al, 2016, Tumor Biology CrossRef
17. DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B
    Yang Fu et al, 2015, Biochemical Journal CrossRef
18. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
    Kin Chan et al, 2015, Nature Genetics CrossRef
19. APOBEC3B expression in human leptomeninges and meningiomas
    Mahlon D. Johnson et al, 2016, Oncology Letters CrossRef
20. Mutation-promoting molecular networks of uncontrolled inflammation
    Hui Zhang et al, 2017, Tumor Biology CrossRef
21. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential
    Kelly Butler et al, 2023, Journal of Hematology & Oncology CrossRef
22. Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas
    Galinos Fanourakis et al, 2016, Experimental and Molecular Pathology CrossRef
23. Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activation
    Jia‐Wern Pan et al, 2021, International Journal of Cancer CrossRef